ALX1-11
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ALX1-11, covering 2021-05-14 to 2021-05-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis [Phase 2]